Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - CA
$ 1.55
-1.27 %
$ 196 M
Market Cap
-4.7
P/E
1. INTRINSIC VALUE
Balance Sheet
OrganiGram Holdings Inc.
| Current Assets | 262 M |
| Cash & Short-Term Investments | 108 M |
| Receivables | 36.6 M |
| Other Current Assets | 118 M |
| Non-Current Assets | 146 M |
| Long-Term Investments | 40.8 M |
| PP&E | 96.2 M |
| Other Non-Current Assets | 8.64 M |
| Current Liabilities | 53.3 M |
| Accounts Payable | 47.1 M |
| Short-Term Debt | 1.09 M |
| Other Current Liabilities | 5.14 M |
| Non-Current Liabilities | 48.5 M |
| Long-Term Debt | 3.37 M |
| Other Non-Current Liabilities | 45.2 M |
EFFICIENCY
Earnings Waterfall
OrganiGram Holdings Inc.
| Revenue | 160 M |
| Cost Of Revenue | 112 M |
| Gross Profit | 47.5 M |
| Operating Expenses | 83.2 M |
| Operating Income | -35.7 M |
| Other Expenses | 9.77 M |
| Net Income | -45.4 M |
RATIOS
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
OrganiGram Holdings Inc.
| Net Income | -45.4 M |
| Depreciation & Amortization | 12.1 M |
| Capital Expenditures | -5.34 M |
| Stock-Based Compensation | 7.18 M |
| Change in Working Capital | 15 M |
| Others | 42.1 M |
| Free Cash Flow | -1.47 M |
Wall Street Analysts Price Targets
OrganiGram Holdings Inc.
OGI has no price targets from Wall Street.
4. DIVIDEND
ANALYSIS
OGI does not distribute dividends.
5. COMPETITION
6. Ownership
Insider Ownership
OrganiGram Holdings Inc.
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
| Date | Value | Insider | Amount | Avg Price |
|---|
7. News
Organigram: Long Term Growth Improving With International And Domestic Cannabis Expansion (Rating Upgrade)
Organigram reported Q4-2024 financial results earlier this week and show improved revenues, profit margins, net loss, and increased cash. The company announced the acquisition of Canadian private cannabis LP Motif Labs which will set Organigram in the top spot in Canada by market share. Organigram has increased its international footprint with an investment in Sanity Group in Germany and in Open Book Extracts in the US.
seekingalpha.com
- 4 weeks ago
Organigram Holdings Inc. (OGI) Q4 2024 Earnings Call Transcript
Organigram Holdings Inc. (NASDAQ:OGI ) Q3 2024 Earnings Conference Call December 18, 2024 8:00 AM ET Company Participants Max Schwartz - Director of IR Beena Goldenberg - CEO Tim Emberg - CCO Greg Guyatt - CFO Conference Call Participants Aaron Grey - Alliance Global Partners Frederico Gomes - ATB Capital Markets Pablo Zuanic - Zuanic & Associates Yewon Kang - Canaccord Genuity Operator Good morning. My name is Rob, and I will be your conference operator today.
seekingalpha.com
- 1 month ago
Canada's Organigram shops for U.S. pot businesses with backing from British American Tobacco
Legal cannabis company grows revenue and narrows its loss as it continues its acquisition push.
marketwatch.com
- 1 month ago
Organigram Reports Fourth Quarter and Fiscal 2024 Results
TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer (“LP”) of cannabis, announced its results for the fourth quarter and twelve months ended September 30, 2024 (“Q4 Fiscal 2024” or “Fiscal 2024”). All financial information in this press release is expressed in Canadian dollars (“$”). Comparable Periods: The Company's results for Q4 Fiscal 2024 and Fiscal 2024 reflect the three-month and 12-month periods ended.
businesswire.com
- 1 month ago
Organigram to Report Fourth Quarter and Fiscal 2024 Results on December 18, 2024
TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its fourth quarter and fiscal 2024 ended September 30, 2024, on Wednesday, December 18, 2024, prior to market open. The Company will host a conference call to discuss its results with details as follows: Date: Wednesday, December 18, 2024 Time: 8:0.
businesswire.com
- 1 month ago
OrganiGram purchasing Motif Labs to become Canada's largest cannabis company by market share, as others retreat
OrganiGram to pay up to C$100 million ($70.7 million) for vape and prerolled cannabis specialist Motif.
marketwatch.com
- 1 month ago
Organigram Acquires Motif, Becoming Canada's Largest Cannabis Company by Market Share
TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), a leading licensed producer of cannabis, is pleased to announce the acquisition of 100% of the issued and outstanding shares of Motif Labs Ltd. (“Motif”), for upfront consideration of $90 million, consisting of $50 million in cash and $40 million of Organigram common shares priced based on the 30 day trading VWAP of $2.3210 on the Toronto Stock Exchange (“TSX”). In addition, Motif share.
businesswire.com
- 1 month ago
Organigram Could Soar In 2026
Organigram's stock is undervalued, trading at a 22% discount to tangible book value, with strong growth projections and a solid financial outlook. The company has a high cash balance and no debt, bolstered by additional investment from British American Tobacco. Analysts expect revenue and adjusted EBITDA to grow significantly in FY25 and FY26, making the stock a compelling buy.
seekingalpha.com
- 1 month ago
Organigram Launches FAST™ Nanoemulsion Gummies
TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, is thrilled to finally launch Edison Sonics gummies, Organigram's inaugural product powered by FAST™, the Company's groundbreaking nanoemulsion technology and a first-to-market innovation. FAST™ products deliver up to ~50% faster onset and improved bioavailability delivering nearly double the cannabinoids at peak effect compared to traditional ed.
businesswire.com
- 1 month ago
Organigram: Why I Still Like It
Organigram's stock has surged 22% since my last analysis, outperforming the cannabis market, yet it remains a buy due to its promising chart and valuation. The fiscal Q3 report exceeded expectations with revenue up 25% and adjusted EBITDA turning positive, highlighting significant financial improvement and strong cash reserves. Analysts have raised their projections for FY25 and FY26, expecting higher revenue and adjusted EBITDA, reinforcing the stock's attractive valuation and growth potential.
seekingalpha.com
- 4 months ago
3 Marijuana Stocks To Watch In The Stock Market Today
Many legal cannabis operators are working to keep pushing the boundaries of the industry. Innovation is key for any growing sector and cannabis is no different. Right now is a pivotal time for the cannabis industry as things are continuously changing. The climate of the sector and the success of companies can have a direct connection to how most marijuana stocks perform, especially during an election year where promises may come along from presidential candidates to better the industry.
marijuanastocks.com
- 4 months ago
Organigram Closes Second Tranche of Previously Announced BAT Private Placement Investment
TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today that on August 30, 2024, the Company closed the second of three tranches (the “Second Tranche”) of the previously announced C$124,559,674 follow-on strategic equity investment (the “Investment”) by BT DE Investments Inc. (the “Investor”), a wholly owned subsidiary of British American Tobacco plc (“BAT”). Pursuant to the Second Tra.
businesswire.com
- 4 months ago
8. Profile
Summary
OrganiGram Holdings Inc. OGI
COUNTRY
CA
INDUSTRY
Drug Manufacturers - Specialty & Generic
MARKET CAP
$ 196 M
Dividend Yield
0.00%
Description
Organigram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including cannabis flowers, cannabis oils, and vaporizers for civilian patients and veterans; adult use recreational cannabis under the Edison Cannabis Co., Trail Blazer, SHRED, SHRED'ems, Big Bag O' Buds, and Monjour brands; and cannabis edibles products and concentrates. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as telephone channels. Organigram Holdings Inc. was founded in 2013 and is headquartered in Moncton, Canada.
Contact
35 English Drive, Moncton, NB, E1E 3X3
https://www.organigram.ca
IPO
Date
May 21, 2019
Employees
914
Officers
Mr. Geoff Riggs
Chief Information Officer
Mr. Gregory Engel
Special Advisor
Max Schwartz
Director of Investor Relations
Mr. Greg Guyatt C.A., CPA
Chief Financial Officer
Ms. Katrina May McFadden
Chief People Officer
Mr. Timothy Emberg
Chief Commercial Officer
Mr. Paolo De Luca C.A., C.F.A
Chief Strategy Officer
Ms. Beena G. Goldenberg
Chief Executive Officer & Director
Ms. Nathalie Batten Kubrick
Senior Vice President of Operations
Ms. Helen Martin
Chief Legal Officer & Corporate Secretary